Is Sustained Virological Response a Marker of Treatment Efficacy in Patients with Chronic Hepatitis C Viral Infection with No Response or Relapse to Previous Antiviral Intervention?

• Kurinchi S. Gurusamy ,

  * E-mail: kurinchi2k@hotmail.com

  Affiliation Department of Surgery, University College London, London, United Kingdom

  ⨯
• Edward Wilson,

  Affiliations Health Economics Group, University of East Anglia, Norwich, United Kingdom, Cambridge Centre for Health Services Research, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Ronald L. Koretz,

  Affiliation Cochrane Hepato Biliary Group, Granada Hills, California, United States of America

  ⨯
• Victoria B. Allen,

  Affiliation Department of Surgery, University College London, London, United Kingdom

  ⨯
• Brian R. Davidson,

  Affiliation Department of Surgery, University College London, London, United Kingdom

  ⨯
• Andrew K. Burroughs,

  Affiliation Sheila Sherlock Liver Centre and Institute of Liver and Digestive Health, Royal Free Hospital, and UCL, London, United Kingdom

  ⨯
• Christian Gluud

  Affiliation Cochrane Hepato-Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet,Copenhagen University Hospital, Copenhagen, Denmark

  ⨯